MasterBrand to Announce First Quarter 2026 Results on May 5
Get Alerts MBC Hot Sheet
Join SI Premium – FREE
BEACHWOOD, Ohio--(BUSINESS WIRE)-- MasterBrand, Inc. (NYSE: MBC, the “Company,” or “MasterBrand”), the largest residential cabinet manufacturer in North America, today announced it will release its first quarter 2026 financial results after the market close on Tuesday, May 5, 2026.
The Company will hold a live conference call and webcast at 4:30 p.m. ET the same day to discuss the financial results and business outlook. Telephone access to the live call will be available at (877) 407-4019 (U.S.) or by dialing (201) 689-8337 (international). The live audio webcast can be accessed on the “Investors” section of the MasterBrand website at www.masterbrand.com.
A telephone replay will be available approximately one hour following completion of the call through May 19, 2026. To access the replay, please dial 877-660-6853 (U.S.) or 201-612-7415 (international). The replay passcode is 13759256. An archived webcast of the conference call will also be available on the "Investors" page of the Company's website.
About MasterBrand:
MasterBrand, Inc. (NYSE: MBC) is the largest manufacturer of residential cabinets in North America and offers a comprehensive portfolio of leading residential cabinetry products for the kitchen, bathroom and other parts of the home. Delivered through our exceptional distribution network, MasterBrand products are available in a wide variety of designs, finishes and styles and span the most attractive categories of the cabinets market: stock, semi-custom and premium cabinetry. Additional information can be found at www.masterbrand.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260407697155/en/
Investor Relations:
[email protected]
Media Contact:
[email protected]
Source: MasterBrand, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Cataltheia Group and Bruno Vision Care Announce Publication of Landmark Clinical Study Validating Deseyne® Extended Depth of Focus Technology for Presbyopia
- Verrica Pharmaceuticals Announces First U.S. Patient Dosed in the Second Pivotal Clinical Trial (COVE-3) of its Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts
- Visually Intuitive Skincare: houry's Color-Changing Depuff Pad Signals Launch in U.S
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share